Ian G. Lockart

St Vincent's Healthcare Campus, UNSW
Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Altered blood-brain barrier permeability is associated with abnormal distant connectivity and regional homogeneity in covert hepatic encephalopathy-A cross-sectional study.

Altered blood-brain barrier permeability is associated with abnormal distant connectivity and regional homogeneity in covert hepatic encephalopathy-A cross-sectional study.

Journal: Hepatology (Baltimore, Md.)

Published: December 09, 2024

Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy.

Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy.

Journal: Hepatology communications

Published: June 01, 2024

A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease.

A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease.

Journal: British journal of clinical pharmacology

Published: April 10, 2024

Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia.

Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia.

Journal: Internal medicine journal

Published: May 02, 2023

Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE.

Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE.

Journal: Hepatology communications

Published: August 12, 2022

Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study.

Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study.

Journal: Journal of gastroenterology and hepatology

Published: May 17, 2022

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.

Journal: Hepatology (Baltimore, Md.)

Published: November 20, 2021

Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply.

Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: August 23, 2021

All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.

All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.

Journal: Journal of gastroenterology and hepatology

Published: May 11, 2021

Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.

Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.

Journal: Alimentary pharmacology & therapeutics

Published: April 16, 2021

Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival.

Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival.

Journal: Journal of viral hepatitis

Published: January 04, 2021

Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers.

Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers.

Journal: Public health research & practice

Published: August 07, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026